| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в травні 2003 (uk)
- im Mai 2003 veröffentlichter wissenschaftlicher Artikel (de)
- article scientifique publié en 2003 (fr)
- artículu científicu espublizáu en mayu de 2003 (ast)
- scientific article published on 01 May 2003 (en)
|
| publication date
| |
| publication date
| |
| author name string
| |
| author name string
| - Kiyoshi Kato
- Ikuo Konishi
- Toshio Nikaido
- Tsutomu Miyamoto
- Junko Uchikawa
- Tsutomu Imai
- Hsien-Chang Shih
|
| rdfs:label
| - Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator (en)
- Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator (nl)
|
| skos:prefLabel
| - Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator (en)
- Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator (nl)
|
| name
| - Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator (en)
- Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator (nl)
|
| author
| |
| author
| |
| title
| |
| title
| - Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1016/S0046-8177(03)00124-2
|
| is about
of | |
| is cites work
of | - Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review
- Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas
- Cell-cycle protein expression in a population-based study of ovarian and endometrial cancers
- Cyclins D1, D3, E, and A in vulvar carcinoma patients
- Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment
- Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy
- Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin
- Expression of p53 in imprint smears of endometrial carcinoma
- Diagnostic utility of phosphatase and tensin homolog, beta-catenin, and p53 for endometrial carcinoma by thin-layer endometrial preparations
- p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review
- p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer
- Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials
- Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma.
- High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma.
- Utility of thin-layer preparations in endometrial cytology: immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesions
- Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data
- Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas
- Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease
- Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.
- Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells
- Expression of immunoreactivity of nuclear findings by p53 and cyclin a in endometrial cytology: Comparison with endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.
- Endometrial Carcinoma: Specific Targeted Pathways.
- A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment
- Cyclin A is a reliable proliferation marker in endometrial cancer cell lines
- Diagnostic value of endometrium associated with papillary metaplastic changes in endometrial cytopathology
- Immunohistochemical features of a papillary squamous cell carcinoma of the endometrium with transitional cell differentiation
- Liquid-based preparation for endometrial cytology--usefulness for predicting the prognosis of endometrial carcinoma preoperatively.
- Cystic clear cell tumor of borderline malignancy of the ovary lacking fibromatous components: report of two cases and a possible new histological subtype
- Validation of Molecular Typing for Endometrial Screening Test That Predicts Benign and Malignant Lesions
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)